A private, invitation-only series designed to bring together leading voices in biotechnology for candid, high-level discussions.
We organize private, invitation-only dinners co-hosted by our Chairman, Stelios Papadopoulos, and CEO, Vangelis Vergetis. Each time we invite a “guest of honor” who provides some overall thoughts and framing for the conversation.
The aim is to enable an open and candid conversation on the forces shaping the industry today. We follow the Chatham House Rule and do not publish any minutes, summary, or participant names and affiliations.
Obviously, the cuisine is always Greek, the participants are opinionated, and the conversation gets increasingly animated as the evening progresses.
Executive Vice President; President of Lilly Oncology and Head of Corporate Business Development, Eli Lilly and Company Board co-Chair, President and Chief Scientific Officer, Regeneron Co-CEO, Corsera Health; Founding CEO, Alnylam; Board member and advisor/venture partner in various biotechnology companies and funds Co-founder and Executive Chairman, Ovid Therapeutics; former CEO, Teva; Board member in various biotechnology companies
Jake Van Naarden
George Yancopoulos MD, PhD
John Maraganore PhD
Jeremy Levin D.Phil, MB BChir
If you would like to be considered for participation or learn
more about the series, we would be glad to hear from you.